A moderately high fat diet promotes salt-sensitive hypertension in obese zucker rats by impairing nitric oxide production.
The objective of this research was to examine the contribution of a moderately high fat (MHF) diet to the development of salt-sensitive hypertension in obese Zucker rats. Lean and obese Zucker rats were fed either a MHF diet or a diet of standard rat chow (control diet) for 10 weeks. From week 4 through week 10, the drinking water was supplemented with 1% NaCl. Blood pressure was measured weekly, and urinary excretion of nitric oxide metabolites (NO(x)) was determined at weeks 4 and 10. At week 10, renal nitric oxide synthase (NOS) activity was assessed in kidney homogenates. Blood pressures of obese, but not lean, rats on the MHF fat diet were significantly increased by salt-supplementation, whereas blood pressures of rats on the control diet were not appreciably affected. NO(x) excretion was increased in response to salt-supplementation in rats on the control diet, with the effect being particularly dramatic in obese rats. After salt-supplementation, NO(x) excretion by rats on the MHF diet was lower than rats on the control diet. In obese rats on the MHF diet, this decrease in NO production was accompanied by a reduction in renal NOS activity. These results indicate that obese rats are more inclined than lean rats to develop diet-induced hypertension in response to a moderately high fat, salt-supplemented diet. Furthermore, they suggest that MHF diet-induced defects in NO production may promote the salt-sensitivity of blood pressure in obese Zucker rats, which appear to require more NO to maintain blood pressure during a salt challenge.
Morrison
Ryan G
RG
Department of Pharmacology, Physiology and Toxicology, Marshall University, Joan C. Edwards School of Medicine, Huntington, West Virginia 25755, USA.
Mills
Caroline
C
Moran
Antoinette L
AL
Walton
Chelsea E
CE
Sadek
Mohamed H
MH
Mangiarua
Elsa I
EI
Wehner
Paulette S
PS
McCumbee
William D
WD
D000818:Animals; D001835:Body Weight; D004032:Diet / Q000009:adverse effects; D004041:Dietary Fats / Q000009:adverse effects*; D004195:Disease Models, Animal; D025461:Feedback, Physiological; D005260:Female; D006973:Hypertension / Q000209:etiology / Q000378:metabolism; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000097:blood; D009566:Nitrates / Q000378:metabolism / Q000652:urine; D009569:Nitric Oxide / Q000172:deficiency* / Q000652:urine; D019001:Nitric Oxide Synthase / Q000096:biosynthesis; D009573:Nitrites / Q000378:metabolism / Q000652:urine; D009748:Nutrition Disorders / Q000150:complications / Q000378:metabolism; D009765:Obesity / Q000150:complications / Q000378:metabolism*; D051381:Rats; D011924:Rats, Zucker; D017673:Sodium Chloride, Dietary / Q000009:adverse effects*
D004041:Dietary Fats; D007328:Insulin; D020738:Leptin; D009566:Nitrates; D009573:Nitrites; D017673:Sodium Chloride, Dietary; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase